Skip to main content
. 2012 Nov 1;3:454–458. doi: 10.7150/jca.4807

Table 3.

Sensitivity analysis varying chemotherapy costs.

Treatment Overall survival months Direct and indirect costs / patient ($) ICER / QALY
Cisplatin 6.5 34,908 --
CP 9.7 → 14.6 36,978 10,994→6,150
CT 9.4 → 14.1 49,071 133,067→66,400